Recent Developments In The Treatment Of (HBR) Patients

Published: 23 January 2021

  • Views:

    Views Icon 61378

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Learn more about the most recent developments in the treatment of (HBR) patients with coronary artery disease through videos, interviews and panel discussions with renowned faculty from highly ranked institutions.

This programme is supported by:

Key Learning Objectives

  • To emphasize the importance of defining high bleeding risk in patients undergoing PCI
  • To increase identification of high bleeding risk patients and learn how to apply this in your clinical practice
  • To highlight the Onyx One Clinical Program, including sub-analysis and the relevance for your daily practice

More from this programme

Part 1

Ischemic and Bleeding Outcomes in Patients With vs. Without Atrial Fibrillation (AF) – insights from the Onyx ONE program

Chapter 1: Ischemic and Bleeding Outcomes in Patients With vs. Without Atrial Fibrillation (AF) – insights from the Onyx ONE program. Question 1: What is the new data from the Onyx ONE clinical program presented at TCT? Question 2: Why was AF patient population important to be included in a sub analysis? Question 3: What are the main findings of the AF sub analysis?
1 session
Ischemic and Bleeding Outcomes in Patients With vs. Without Atrial Fibrillation (AF) – insights from the Onyx ONE program Watch now

Part 2

Complex PCI with 1-month DAPT in HBR patients - insights from the Onyx ONE program

Chapter 2: Complex PCI with 1-month DAPT in HBR patients – insights from the Onyx ONE program. Question 1: Why was Complex PCI patient population important to be included in a sub analysis? Question 2: What are the main findings of the complex PCI sub analysis? Question 3: How relevant these data (both AF and complex PCI) are for your daily practice?
1 session
Chapter 2: Complex PCI with 1-month DAPT in HBR patients - insights from the Onyx ONE program Watch now

Part 3

High Bleeding Risk Patients: Identifying the ‘forgotten’ population – Do we have the tools?

In this video both physicians will discuss the importance of identification High Bleeding Risk patients, as also the specific mobile application (ARC HBR Application) that has been developed to quickly identify HBR patients at the bedside. Dr Colleran and Dr Morice will also look into the future and review the next steps the Academic Research Consortium is taking for the identification and treatment options for HBR patients undergoing PCI.
1 session
Chapter 3: High Bleeding Risk Patients: Identifying the ‘forgotten’ population – Do we have the tools? Watch now

Faculty Biographies

Darren Mylotte

Darren Mylotte

Consultant Cardiologist

Dr Darren Mylotte graduated from RCSI Medical School in 2001, obtained membership of the Royal College of Physicians in Ireland in 2004, and completed the Irish Cardiology Specialist Training Scheme. He and was conferred with a Doctor of Medicine (MD) thesis in 2010 by the Royal College of Surgeons in Ireland and has also undertaken a PhD thesis. N the subject of Transcatheter Aortic Valve Implantation (TAVI) at the world renowned ThoraxCentre in Rotterdam, The Netherlands.

 

View full profile
David Kandzari

David Kandzari

Director of Interventional Cardiology and Chief Scientific Officer

Dr David Kandzari obtained his undergraduate degree from Duke University School of Medicine then completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. 

Dr Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 150 studies, book chapters and scientific reviews. Dr Kandzari is board certified in internal medicine and cardiovascular diseases and is certified by the Board of Interventional Cardiology. He specializes in interventional cardiology, peripheral arterial disease and cardiovascular medicine. His…

View full profile